tiprankstipranks
Ironwood Pharmaceuticals (IRWD)
NASDAQ:IRWD
US Market

Ironwood Pharma (IRWD) Income Statement

424 Followers

Ironwood Pharma Income Statement

Last quarter (Q4 2025), Ironwood Pharma's total revenue was $47.71M, a decrease of -47.31% from the same quarter last year. In Q4, Ironwood Pharma's net income was $-2.28M. See Ironwood Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 296.15M$ 351.41M$ 442.74M$ 410.60M$ 413.75M
Gross Profit
$ 294.27M$ 343.86M$ 436.59M$ 409.18M$ 343.35M
Operating Expenses
$ 175.51M$ 250.73M$ 1.38B$ 158.84M$ 111.09M
Depreciation and Amortization
$ 1.88M$ 2.01M$ 1.57M$ 1.42M$ 1.52M
EBITDA
$ 104.65M$ 97.73M$ 197.41M$ 261.44M$ 233.74M
Operating Income
$ 118.76M$ 93.12M$ -945.43M$ 250.34M$ 232.26M
Other Income/Expenses
$ -48.73M$ -27.93M$ -2.64M$ 2.08M$ -31.60M
Pretax Income
$ 70.03M$ 65.20M$ -948.07M$ 252.42M$ 200.66M
Net Income
$ 24.02M$ 880.00K$ -1.00B$ 175.06M$ 528.45M
Per Share Metrics
Basic EPS
$ 0.15$ 0.01$ -6.45$ 1.13$ 3.26
Diluted EPS
$ 0.15$ 0.01$ -6.45$ 0.96$ 3.21
Weighted Average Shares Outstanding
162.22M 159.08M 155.44M 154.37M 162.25M
Weighted Average Shares Outstanding (Diluted)
177.76M 160.08M 155.44M 186.31M 164.42M
Currency in USD

Ironwood Pharma Earnings and Revenue History